Showing results (551-560 of 609) with videos related to
Sort By:
Pageof 61
Mbio|September 9, 2020
Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal PeptidaseHomer Pantua, Elizabeth Skippington, Marie-Gabrielle Braun, et al.The Journal of Clinical Investigation|May 3, 2017
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunctionChrista F Gaskill, Erica J Carrier, Jonathan A Kropski, et al.Plos Biology|September 3, 2015
Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of Staphylococcus aureusMaisem Laabei, Anne-Catrin Uhlemann, Franklin D Lowy, et al.American Journal of Respiratory and Critical Care Medicine|November 11, 2022
Molecular Function and Contribution of TBX4 in Development and DiseaseJustyna A Karolak, Carrie L Welch, Christian Mosimann, et al.Pulmonary Circulation|July 7, 2017
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionRobert A Egnatchik, Evan L Brittain, Amy T Shah, et al.The European Respiratory Journal|June 2, 2019
Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertensionCsaba Galambos, Mary P Mullen, Joseph T Shieh, et al.Circulation|October 22, 2015
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular MetabolismXinping Chen, Megha Talati, Joshua P Fessel, et al.Journal of the American Heart Association|October 8, 2021
Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary HypertensionCaroline M Daly, Megan Griffiths, Catherine E Simpson, et al.Pediatric Pulmonology|October 11, 2024
Outpatient clinical care for bronchopulmonary dysplasia: A survey of the BPD collaborativePaul E Moore, Lystra P Hayden, Natalie M Villafranco, et al.The Journal of Clinical Investigation|December 7, 2007
In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammationDhaya Seshasayee, Wyne P Lee, Meijuan Zhou, et al.Pageof 61